KURA - Financial Reports List - Kura Oncology, Inc. - IntrinsicAlpha

Kura Oncology, Inc. KURA

Healthcare - Biotechnology - NASDAQ - US

$ 5.76

-2.21 %

$ 465 M

Market Cap

-2.85

P/E

FINANCIAL REPORTS

Reports

Report			Date	Revenue YoY	Net Income YoY	Operating Income YoY	View
Quarterly Report	Q4	8-K	2024-12-31	4142.76%	55.09%	100.00%
Annual Report	FY	10-K	2024-12-31	0.00%	-13.99%	-16.52%
Quarterly Report	Q3	8-K	2024-09-30	0.00%	-40.94%	-55.13%
Quarterly Report	Q2	8-K	2024-06-30	0.00%	-36.75%	-41.00%
Quarterly Report	Q1	8-K	2024-03-31	0.00%	-59.75%	-48.08%
Quarterly Report	Q4	8-K	2023-12-31	0.00%	-28.32%	-32.24%
Annual Report	FY	10-K	2023-12-31	0.00%	-12.17%	-17.91%
Quarterly Report	Q3	8-K	2023-09-30	0.00%	-8.73%	-5.49%
Quarterly Report	Q2	8-K	2023-06-30	0.00%	-5.21%	-15.05%
Quarterly Report	Q1	8-K	2023-03-31	0.00%	5.43%	-13.31%

1